1. Home
  2. HCAT vs PYXS Comparison

HCAT vs PYXS Comparison

Compare HCAT & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Health Catalyst Inc

HCAT

Health Catalyst Inc

HOLD

Current Price

$1.27

Market Cap

97.9M

Sector

Technology

ML Signal

HOLD

Logo Pyxis Oncology Inc.

PYXS

Pyxis Oncology Inc.

HOLD

Current Price

$1.67

Market Cap

82.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCAT
PYXS
Founded
2008
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.9M
82.3M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
HCAT
PYXS
Price
$1.27
$1.67
Analyst Decision
Hold
Strong Buy
Analyst Count
10
5
Target Price
$2.53
$7.00
AVG Volume (30 Days)
581.9K
377.5K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.03
EPS
N/A
N/A
Revenue
$311,136,000.00
$13,858,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7,043.98
P/E Ratio
N/A
N/A
Revenue Growth
1.48
N/A
52 Week Low
$0.96
$0.97
52 Week High
$5.06
$5.55

Technical Indicators

Market Signals
Indicator
HCAT
PYXS
Relative Strength Index (RSI) 47.60 51.71
Support Level $1.02 $1.28
Resistance Level $2.41 $1.74
Average True Range (ATR) 0.11 0.16
MACD 0.03 0.00
Stochastic Oscillator 60.78 19.74

Price Performance

Historical Comparison
HCAT
PYXS

About HCAT Health Catalyst Inc

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

Share on Social Networks: